Home > Products > CD64 & HER2
> Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Fv-IgG)
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Fv-IgG) (CAT#: BSDG-128)
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-CD64 IgG with similar domains from an anti-HER2 antibody via short peptide linkers, or vice versa. This BsAb can retarget neutrophils cells to tumor cells. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
There are currently no customer reviews or questions for Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Fv-IgG) (BSDG-128). Click the button below to contact us or submit your feedback about this product.